GPC Biotech AG Expects More Job Cuts

NEW YORK — German biotech drug maker GPC Biotech AG said Thursday it reaffirmed its full-year revenue guidance and expects to implement cost-cutting measures, including a significant number of job cuts.

MORE ON THIS TOPIC